Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study
Frontiers in Oncology · 29.07.2026 · 16
DOI: 10.3389/fonc.2026.1876009 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Oncology, online erschienen am 29.07.2026. Verfasst von Manideepa Maji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Institute of Child Health, Noida, India. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Febrile neutropenia (FN) remains a major cause of morbidity and mortality in paediatric haemato-oncology, but routinely available determinants of adverse in-hospital outcome remain incompletely characterised. We aimed to identify baseline clinical, haematological, biochemical, and microbiological factors associated with in-hospital mortality and prolonged fever.
Methods
We conducted a prospective single-centre cohort study of 90 consecutive FN admissions in paediatric haemato-oncology patients. Thirty-nine prespecified baseline predictors were evaluated using Firth penalised-likelihood logistic regression. Multivariable models were prespecified on clinical grounds, and discrimination was internally validated using 500 bootstrap replicates with optimism correction. Prolonged fever was defined as time to defervescence >5 days, with death before defervescence counted as an event.
Results
Of 86 mortality-evaluable episodes, 16 children died in hospital (18.6%). In the multivariable mortality model, any respiratory support (adjusted odds ratio [aOR], 11.9; 95% CI, 2.5–56.9) and lower admission albumin (aOR, 0.29 per 1 g/dL increase; 95% CI, 0.11–0.77) showed the strongest associations with death. Active disease (aOR 3.5, 95% CI 0.87–14.2) and gram-negative bacteraemia (aOR 4.2, 95% CI 0.93–18.9) showed directionally adverse but imprecise associations. The bootstrap-corrected AUC was 0.88. Of 60 classifiable episodes for the secondary outcome, 31 (51.7%) had prolonged fever. Prolonged fever was associated with older age (aOR 1.24 per year, 95% CI 1.05–1.48), lower albumin (aOR 0.31 per 1 g/dL increase, 95% CI 0.12–0.82), any respiratory support (aOR 10.0, 95% CI 0.98–102.0), and gram-negative bacteraemia (aOR 5.5, 95% CI 1.01–30.3). The bootstrap-corrected AUC was 0.85. Neutropenia depth and platelet count were not independently associated with either outcome.
Conclusion
In paediatric haemato-oncology patients with FN, adverse in-hospital outcomes were associated mainly with early or evolving respiratory compromise, lower admission albumin, active disease, and gram-negative bacteraemia. Three of these factors, together with age, were associated with prolonged fever or death before defervescence among classifiable episodes. Albumin should be interpreted as a dynamic marker of acute inflammatory burden, capillary leak, and host reserve rather than as a standalone nutritional measure. These routinely available variables may support exploratory bedside risk appraisal, but external validation is required before clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduate Institute of Child Health, Noida, India.
- Hull York Medical School, University of Hull, Hull, United Kingdom.
- Department of Haematology, Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
- Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Zitieren
APA
Maji, M., Radhakrishnan, N., Verma, S., Diptivilasa, A., & Mandal, S. (2026). Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1876009
Vancouver
Maji M, Radhakrishnan N, Verma S, Diptivilasa A, Mandal S. Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1876009
BibTeX
@article{Maji2026,
author = {Maji, Manideepa and Radhakrishnan, Nita and Verma, Shruti and Diptivilasa, Aishvarya and Mandal, Saikat},
title = {Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1876009}
}
EUVIMED